Fifth Third Bancorp
ALDR

Fifth Third Bancorp’s Alder Biopharmaceuticals ALDR Stock Holding History

Fifth Third Bancorp’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,276
Closed -$27K – 2304
2017
Q1 		$27K Buy
1,276
+185
+17% +$4.09K ﹤0.01% 1491
2016
Q4 		$23K Sell
1,091
-836
-43% -$21.7K ﹤0.01% 1584
2016
Q3 		$63K Buy
1,927
+427
+28% +$13K ﹤0.01% 1245
2016
Q2 		$37K Buy
+1,500
New +$40.6K ﹤0.01% 1398
2015
Q4 		– Sell
-25
Closed -$1K – 2963
2015
Q3 		$1K Buy
+25
New +$1.06K ﹤0.01% 2831

Other funds holding ALDR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return